Question special
Faculty

What is the recommendation for those patients who are under therapeutic anticoagulation for moderate disease and then develop severe COVID? Patients were excluded if they already had prior therapeutic anticoagulation in the REMAP-CAP but not in ATTACC and ACTIV-4a severe arm.